CYP17A1 and breast cancer: Conclusion. The BRCA1 founder mutation and genetic polymorphisms in CYP1A1 (Val) and CYP17 (A1) can increase the BC risk among Inuit women and the risk increase with higher serum levels of PFOS and PFOA.